As of Apr 20
| -0.44 / -0.85%|
The 20 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 65.00, with a high estimate of 78.00 and a low estimate of 45.00. The median estimate represents a +27.03% increase from the last price of 51.17.
The current consensus among 23 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.